Sichuan Gulin Gansu Pharmaceutical

Sichuan Gulin Gansu Pharmaceutical is a specialized Chinese pharmaceutical firm focused on the development and production of Traditional Chinese Medicine (TCM) for liver diseases. The company's core business revolves around its proprietary product, Gansu Granules, which is extracted from the herb Penthorum chinense Pursh. This flagship product is widely used in China for treating hepatitis, liver fibrosis, and cholecystitis. Following its acquisition by Kelun Pharmaceutical, the company has expanded its manufacturing capabilities to include multiple dosage forms such as tablets and capsules. It maintains a strong presence in the domestic hepatology market, leveraging its GMP-certified facilities in Sichuan to supply national healthcare providers. The company is recognized as a key high-tech enterprise in the Sichuan province for its contributions to modernized TCM.